| __timestamp | Gilead Sciences, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 293000 |
| Thursday, January 1, 2015 | 3014000000 | 1002000 |
| Friday, January 1, 2016 | 5098000000 | 888000 |
| Sunday, January 1, 2017 | 3734000000 | 19623000 |
| Monday, January 1, 2018 | 5018000000 | 30421000 |
| Tuesday, January 1, 2019 | 9106000000 | 34794000 |
| Wednesday, January 1, 2020 | 5039000000 | 28304000 |
| Friday, January 1, 2021 | 5363000000 | 56886000 |
| Saturday, January 1, 2022 | 4977000000 | 100894000 |
| Sunday, January 1, 2023 | 6923000000 | 159765000 |
| Monday, January 1, 2024 | 5907000000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Gilead Sciences, Inc. and Viridian Therapeutics, Inc. have shown contrasting trajectories in their R&D investments. Gilead, a stalwart in the industry, has consistently invested heavily, with a peak in 2019 where their R&D expenses surged by over 200% compared to 2014. In contrast, Viridian, a smaller player, has shown a remarkable growth trajectory, increasing its R&D spending by an astounding 54,000% from 2014 to 2023. This stark difference highlights the diverse strategies within the biotech sector, where established giants and emerging innovators both play crucial roles in advancing medical science. As we look to the future, these investments will likely shape the next wave of breakthroughs in healthcare.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
AbbVie Inc. or Gilead Sciences, Inc.: Who Invests More in Innovation?
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Novartis AG and Gilead Sciences, Inc.
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Gilead Sciences, Inc. and Axsome Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.